The researchers examined data from the
Organ Procurement and Transplantation Network (OPTN) / United Network for Organ Sharing (UNOS), the nation's organ transplant network, on all reported «eligible deaths,» — defined as potential brain - dead organ donors age 70 years or less without any medical conditions precluding donation — from 2008 to
Organ Procurement and Transplantation Network (OPTN) / United Network for
Organ Sharing (UNOS), the nation's organ transplant network, on all reported «eligible deaths,» — defined as potential brain - dead organ donors age 70 years or less without any medical conditions precluding donation — from 2008 to
Organ Sharing (UNOS), the nation's
organ transplant network, on all reported «eligible deaths,» — defined as potential brain - dead organ donors age 70 years or less without any medical conditions precluding donation — from 2008 to
organ transplant network, on all reported «
eligible deaths,» — defined as potential brain - dead
organ donors age 70 years or less without any medical conditions precluding donation — from 2008 to
organ donors age 70 years or less without any medical conditions precluding donation — from 2008 to 2013.
The combo is then injected into people who have been declared brain dead — M. D. Anderson patients who often wished to be
organ donors but weren't
eligible, so their families agreed to this study instead — to see which blood vessels the peptide hooks up to.
The researchers note that these data alone do not capture all potential deceased
organ donors in the U.S., as the current definition of an
eligible death excludes potential
donors over age 70, and those classified as a «donation after cardiac death»
donor, both of which broaden the pool of available
donors.